Skip to main content
SpringerLink
Log in

Recurrent CD: Medical Prophylaxis

  • Chapter
Crohn’s Disease

  • 2098 Accesses

Abstract

Post-operative recurrence of Crohn’s disease is a significant problem with endoscopic recurrence rates reported to be between 70 and 90 % within 1 year. In addition 70 % of patients will proceed to a second operation over the course of their lifetime. Prevention of this post-operative recurrence is essential and the post-operative setting should be viewed as the ideal opportunity to prevent symptomatic disease and need for future surgery. Utilizing a preventative and treatment strategy based on patient risk with frequent objective monitoring of disease and titration of medical therapy based on these objective findings, future disability, and surgery may be avoided in the majority of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CD:

Crohn’s disease

FC:

Fecal calprotectin

IMM:

Immunomodulator

References

  1. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99:956–63.

    CAS  PubMed  Google Scholar 

  2. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut. 1992;33:331–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn’s disease. Experience with 1379 patients. Ann Surg. 1991;214:230–8. discussion 8–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Terdiman JP. Prevention of postoperative recurrence in Crohn’s disease. Clin Gastroenterol Hepatol. 2008;6:616–20.

    Article  PubMed  Google Scholar 

  5. Sachar DB. Patterns of postoperative recurrence in Crohn’s disease. Scand J Gastroenterol Suppl. 1990;172:35–8.

    Article  CAS  PubMed  Google Scholar 

  6. Sachar DB. The problem of postoperative recurrence of Crohn’s disease. Med Clin North Am. 1990;74:183–8.

    CAS  PubMed  Google Scholar 

  7. Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, et al. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108:1731–42.

    Article  CAS  PubMed  Google Scholar 

  8. Renna S, Camma C, Modesto I, Cabibbo G, Scimeca D, Civitavecchia G, et al. Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn’s disease. Gastroenterology. 2008;135:1500–9.

    Article  CAS  PubMed  Google Scholar 

  9. Cho SM, Cho SW, Regueiro M. Postoperative management of Crohn disease. Med Clin North Am. 2010;94:179–88.

    Article  CAS  PubMed  Google Scholar 

  10. Cameron JL, Hamilton SR, Coleman J, Sitzmann JV, Bayless TM. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann Surg. 1992;215:546–51. discussion 51-2.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Whelan G, Farmer RG, Fazio VW, Goormastic M. Recurrence after surgery in Crohn’s disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology. 1985;88:1826–33.

    CAS  PubMed  Google Scholar 

  12. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn’s disease. Br J Surg. 2000;87:1697–701.

    Article  CAS  PubMed  Google Scholar 

  13. D’Haens GR, Gasparaitis AE, Hanauer SB. Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn’s disease. Gut. 1995;36:715–7.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut. 1988;29:588–92.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann Surg. 2000;231:38–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology. 1998;115:259–67.

    Article  CAS  PubMed  Google Scholar 

  17. D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262–7.

    Article  PubMed  Google Scholar 

  18. McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O’Rourke K, Andrews DF, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology. 1995;109:404–13.

    Article  CAS  PubMed  Google Scholar 

  19. Calabrese E, Petruzziello C, Onali S, Condino G, Zorzi F, Pallone F, et al. Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis. 2009;15:1635–42.

    Article  PubMed  Google Scholar 

  20. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol Hepatol. 2010;8:591–9 e1; quiz e78–9.

    Google Scholar 

  22. Sorrentino D, Terrosu G, Paviotti A, Geraci M, Avellini C, Zoli G, et al. Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn’s disease: partial benefit by infliximab—a pilot study. Dig Dis Sci. 2012;57:1341–8.

    Article  CAS  PubMed  Google Scholar 

  23. Wright E, De Cruz P, Kamm M, Hamilton A, Hamilton K, Ritchie K, et al. Feacal calprotectin is superior to feacal lactoferrin and S100A12 as a surrogate marker for post-operative Crohn’s disease endoscopic recurrence. Prospective longitudinal endoscopic validation. Results from the POCER study. Gastroenterology. 2014;146:S-174.

    Google Scholar 

  24. Lobaton T, Lopez-Garcia A, Rodriguez-Moranta F, Ruiz A, Rodriguez L, Guardiola J. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn’s disease. J Crohns Colitis. 2013;7:e641–51.

    Article  PubMed  Google Scholar 

  25. Yamamoto T, Kotze PG. Is fecal calprotectin useful for monitoring endoscopic disease activity in patients with postoperative Crohn’s disease? J Crohns Colitis. 2013;7:e712.

    Article  PubMed  Google Scholar 

  26. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Chermesh I, Tamir A, Reshef R, Chowers Y, Suissa A, Katz D, et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn’s disease. Dig Dis Sci. 2007;52:385–9.

    Article  PubMed  Google Scholar 

  28. Cottone M, Camma C. Mesalamine and relapse prevention in Crohn’s disease. Gastroenterology. 2000;119:597.

    Article  CAS  PubMed  Google Scholar 

  29. Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn’s disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther. 2003;17:517–23.

    Article  CAS  PubMed  Google Scholar 

  30. Sutherland LR, Martin F, Bailey RJ, Fedorak RN, Poleski M, Dallaire C, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease. The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. Gastroenterology. 1997;112:1069–77.

    Article  CAS  PubMed  Google Scholar 

  31. Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2003:CD000301.

    Google Scholar 

  32. Hellers G, Cortot A, Jewell D, Leijonmarck CE, Lofberg R, Malchow H, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn’s disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999;116:294–300.

    Article  CAS  PubMed  Google Scholar 

  33. Rutgeerts P, Van Assche G, Vermeire S, D’Haens G, Baert F, Noman M, et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856–61.

    Article  CAS  PubMed  Google Scholar 

  34. D’Haens GR, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123–9.

    Article  PubMed  Google Scholar 

  35. Peyrin-Biroulet L, Deltenre P, Ardizzone S, D’Haens G, Hanauer SB, Herfarth H, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol. 2009;104:2089–96.

    Article  CAS  PubMed  Google Scholar 

  36. Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136:441–50. quiz 716.

    Article  CAS  PubMed  Google Scholar 

  37. Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. Clin Gastroenterol Hepatol. 2014;12:1494–502.

    Article  CAS  PubMed  Google Scholar 

  38. De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Gorelik A, Liew D, et al. 1161 adalimumab prevents post-operative Crohn’s disease recurrence, and is superior to thiopurines: early results from the POCER study. Gastroenterology. 2012;142:S-212.

    Google Scholar 

  39. De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany S, Gorelik A, et al. 925j optimising post-operative Crohn’s disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. Gastroenterology. 2013;144:S-164.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Gastroenterology, Hepatology and Nutrition, The University of Chicago Medicine, 5841 S. Maryland Avenue, MC4076, Room M410, Chicago, IL, 60637, USA

    Britt Christensen BSc, MBBS, MPH & David T. Rubin MD

Authors
  1. Britt Christensen BSc, MBBS, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David T. Rubin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David T. Rubin MD .

Editor information

Editors and Affiliations

  1. Department of Surgery, University of Washington Medical Center, Seattle, Washington, USA

    Alessandro Fichera

  2. Department of Surgery, University of Washington Medical Center, Seattle, Washington, USA

    Mukta K. Krane

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Christensen, B., Rubin, D.T. (2015). Recurrent CD: Medical Prophylaxis. In: Fichera, A., Krane, M. (eds) Crohn’s Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-14181-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14181-7_16

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14180-0

  • Online ISBN: 978-3-319-14181-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation